AI
BSX icon

Atria Investments’s Boston Scientific BSX Stock Holding History

Atria Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
31,772
-30,879
-49% -$1.68M 0.01% 954
2026
Q1 		$3.93M Sell
62,651
-12,009
-16% -$961K 0.04% 441
2025
Q4 		$7.12M Sell
74,660
-2,816
-4% -$276K 0.08% 272
2025
Q3 		$7.56M Buy
77,476
+35,788
+86% +$3.71M 0.09% 256
2025
Q2 		$4.48M Sell
41,688
-2,859
-6% -$289K 0.05% 413
2025
Q1 		$4.49M Buy
44,547
+18
+0% +$1.81K 0.06% 405
2024
Q4 		$3.98M Sell
44,529
-604
-1% -$53.2K 0.05% 426
2024
Q3 		$3.78M Sell
45,133
-2,823
-6% -$223K 0.05% 441
2024
Q2 		$3.69M Buy
47,956
+3,202
+7% +$234K 0.05% 431
2024
Q1 		$3.07M Buy
44,754
+4,944
+12% +$318K 0.04% 504
2023
Q4 		$2.3M Sell
39,810
-7,600
-16% -$406K 0.04% 545
2023
Q3 		$2.5M Buy
47,410
+10,926
+30% +$573K 0.04% 485
2023
Q2 		$1.97M Buy
36,484
+5,587
+18% +$292K 0.04% 561
2023
Q1 		$1.55M Buy
30,897
+3,802
+14% +$179K 0.03% 639
2022
Q4 		$1.25M Buy
+27,095
New +$1.17M 0.03% 673
2022
Q3 		– Sell
-27,107
Closed -$1.01M – 741
2022
Q2 		$1.01M Sell
27,107
-1,190
-4% -$48.4K 0.02% 745
2022
Q1 		$1.25M Sell
28,297
-5,030
-15% -$218K 0.02% 752
2021
Q4 		$1.42M Sell
33,327
-6,036
-15% -$254K 0.03% 693
2021
Q3 		$1.71M Buy
39,363
+7,697
+24% +$341K 0.03% 589
2021
Q2 		$1.35M Buy
+31,666
New +$1.33M 0.03% 656
2020
Q1 		– Sell
-12,031
Closed -$544K – 628
2019
Q4 		$544K Buy
+12,031
New +$503K 0.01% 756
2019
Q3 		– Sell
-4,953
Closed -$209K – 871
2019
Q2 		$209K Buy
+4,953
New +$191K 0.01% 893
2018
Q3 		– Sell
-6,201
Closed -$203K – 978
2018
Q2 		$203K Buy
+6,201
New +$187K 0.01% 911

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Atria Investments's BSX Position: Q2 2026 in Review

Atria Investments reduced its Boston Scientific (BSX) stake by 49% in Q2 2026, selling an estimated $1.68M and leaving 31,772 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #954.

Atria Investments first reported a position in BSX in Q2 2018 and has held it in 23 quarters since. The position peaked at $7.56M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Atria Investments held 31,772 shares of Boston Scientific worth $1.36M as of Q2 2026.
  • Atria Investments sold 30,879 Boston Scientific shares in Q2 2026, an estimated $1.68M.
  • Boston Scientific made up 0.01% of Atria Investments's portfolio in Q2 2026, its #954 holding.
  • Atria Investments first reported a position in Boston Scientific in Q2 2018 and has held it in 23 quarters since.
  • Atria Investments's Boston Scientific position peaked at $7.56M in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.